Zhou S - Search Results

1

APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations.

Hong Y, Ren T, Wang X, Liu X, Fei Y, Meng S, Han X, Sun C, Shen H, Li L, Qiu L, Qian Z, Zhou S, Zhang H, Wang X. Hong Y, et al. Among authors: zhou s. Leukemia. 2022 Sep;36(9):2269-2280. doi: 10.1038/s41375-022-01634-w. Epub 2022 Jul 14. Leukemia. 2022. PMID: 35835991

2

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

3

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

4

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

5

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.

Xu Y, Wang H, Zhou S, Yu M, Wang X, Fu K, Qian Z, Zhang H, Qiu L, Liu X, Wang P. Xu Y, et al. Among authors: zhou s. Leuk Lymphoma. 2013 Jul;54(7):1396-404. doi: 10.3109/10428194.2012.743657. Epub 2012 Nov 26. Leuk Lymphoma. 2013. PMID: 23101661

6

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.

Wang XH, Zhou SY, Qian ZZ, Zhang HL, Qiu LH, Song Z, Zhao J, Wang P, Hao XS, Wang HQ. Wang XH, et al. Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):117-25. doi: 10.1517/17425255.2013.738667. Epub 2012 Nov 8. Expert Opin Drug Metab Toxicol. 2013. PMID: 23134084 Clinical Trial.

7

[Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues].

Xu YL, Wang HQ, Qian ZZ, Song Z, Zhou SY, Zhang HL, Qiu LH, Wang XH, Wang P. Xu YL, et al. Zhonghua Zhong Liu Za Zhi. 2013 Jun;35(6):450-5. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24119906 Chinese.

8

[Prognostic factors of nasal NK/T-cell lymphoma].

Ma Q, Zhang HL, Liu X, Zhou SY, Qian ZZ, Zhai QL, Fu K, Wang HQ. Ma Q, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Dec;48(12):1011-6. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013. PMID: 24507001 Chinese.

9

A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors.

Qian Z, Wang X, Song Z, Zhang H, Zhou S, Zhao J, Wang H. Qian Z, et al. Among authors: zhou s. Biomed Res Int. 2015;2015:809714. doi: 10.1155/2015/809714. Epub 2015 Mar 19. Biomed Res Int. 2015. PMID: 25866811 Free PMC article. Clinical Trial.

10

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.

Dong L, Lv H, Li W, Song Z, Li L, Zhou S, Qiu L, Qian Z, Liu X, Feng L, Meng B, Fu K, Wang X, Pan-Hammarström Q, Wang P, Wang X, Zhang H. Dong L, et al. Among authors: zhou s. Oncotarget. 2016 May 31;7(22):33350-62. doi: 10.18632/oncotarget.9061. Oncotarget. 2016. PMID: 27147575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,670 results

Search Page